This review provides an updated, practical approach to the individualized management of patients with atrial fibrillation, covering anticoagulation, rate control, and rhythm control strategies.
May guide individualized AF decisions now; leaves open need for prospective trials on specific strategies.
Atrial fibrillation is the most commonly encountered clinical arrhythmia and continues to grow in incidence. Current management involves highly individualised therapies based on underlying concomitant disease processes and symptoms. Moreover, there are numerous therapeutic permutations involving anticoagulation, rate-limitation and antiarrhythmic strategies. This review serves to update the clinician with a practical approach to each patient population and on current advances in management.
No takes yet. Share an insight, caveat, or question.
McLeod et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: